Trials / Recruiting
RecruitingNCT03371641
In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- University Hospital, Rouen · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study aims to validate that PLGF is a biomarker of cerebral lesions and therefore of secondary developmental disorders and disabilities that will be best diagnosed at 2 and 6 years of age.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | ASQ parental questionnaire | ASQ parental questionnaire |
| BEHAVIORAL | Development scales | WPPSI - IV and NEPSY development scales |
| BEHAVIORAL | Scale of Conners | Scale of Conners |
| BEHAVIORAL | SCQ Questionnaire | SCQ questionnaire |
| PROCEDURE | Blood sample (mother) | Blood sample (mother) before delivery |
| PROCEDURE | Cord blood sample | Cord blood sample after delivery |
| PROCEDURE | Placenta sample | Placenta sample |
Timeline
- Start date
- 2017-01-27
- Primary completion
- 2026-03-27
- Completion
- 2026-03-27
- First posted
- 2017-12-13
- Last updated
- 2026-02-06
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03371641. Inclusion in this directory is not an endorsement.